Dr. E. Badiavas

Badiavas Biologics is a clinical-stage biotechnology company focused on the development of regenerative cell therapies for severe dermatological conditions and chronic wounds. Founded by Dr. Evangelos Badiavas, a prominent researcher at the University of Miami, the company specializes in utilizing bone marrow-derived cells to stimulate tissue repair. Their lead programs involve the application of autologous and allogeneic stem cells to treat hard-to-heal cutaneous ulcers and genetic disorders like Epidermolysis Bullosa. The company's approach leverages the natural signaling and regenerative capacity of mesenchymal and hematopoietic cells to restore skin integrity. Badiavas Biologics operates at the intersection of academic research and commercial development to address significant unmet needs in wound care.